POA Pharma Scandinavia AB signs a distribution agreement with Orpharma, Melbourne, AUSTRALIA for marketing and sale of SPC Flakes® and Salovum® in Australia and New Zeeland.
POA Pharma Scandinavia and Desma Healtcare have Signed a Licensing Agreement for the distribution, sale and marketing of the product Akineton in Denmark, Finland, Norway and Sweden.
The clinical efficacy of Antisecretory Factor (AF) in Ménière’s disease was presented. This took place at the minisymposium: Antisecretory Factor: A clinical innovation in Ménière’s Disease? The clinical studies, which were presented, answered with a resounding Yes!
POA Pharma Scandinavia AB | Ebbe Lieberathsgatan 21 | Box 24026, 400 22 Göteborg | Phone: +46 (0) 31 788 05 99